Trial Profile
Full-dose Atorvastatin Versus Conventional Medical Therapy After Non-ST-elevation Acute Myocardial Infarction in Patients With Advanced Non-revascularisable Coronary Artery Disease.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Sep 2011
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atrial fibrillation; Cardiovascular disorders; Coronary artery disease; Myocardial infarction
- Focus Therapeutic Use
- Acronyms APRIRE
- 31 Aug 2011 Results of a secondary endpoint analysis (incidence of atrial fibrillation) presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
- 07 Sep 2010 New trial record